Synergism between CRISPR/Cas9 and LASER ART leads to elimination of HIV-1 with no rebound in Humanized Mice

被引：1
|
作者：
Gendelman, Howard [1 ,3 ]
Dash, Prasanta [1 ,3 ]
Edagwa, Benson [1 ,3 ]
Gorantla, Santhi [1 ,3 ]
Kaminski, Rafal [2 ]
Bella, Ramona [2 ]
Young, Won-Bin [2 ]
Khalili, Kamel [2 ]
机构：
[1] Univ Nebraska Med Ctr, Omaha, NE USA
[2] Temple Univ, Lewis Katz Sch Med, Dept Neurosci, Philadelphia, PA 19122 USA
[3] Univ Nebraska, Dept Pharmacol & Expt Neurosci, Omaha, NE 68182 USA
来源：
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES | 2018年 / 77卷
关键词：
D O I：
10.1097/01.qai.0000532603.53717.02
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
D-110
引用
收藏
页码：42 / 42
页数：1
相关论文
共 50 条
  • [21] Elimination of HIV-1 Genomes from Human T-lymphoid Cells by CRISPR/Cas9 Gene Editing
    Rafal Kaminski
    Yilan Chen
    Tracy Fischer
    Ellen Tedaldi
    Alessandro Napoli
    Yonggang Zhang
    Jonathan Karn
    Wenhui Hu
    Kamel Khalili
    Scientific Reports, 6
  • [22] Elimination of HIV-1 Genomes from Human T-lymphoid Cells by CRISPR/Cas9 Gene Editing
    Kaminski, Rafal
    Chen, Yilan
    Fischer, Tracy
    Tedaldi, Ellen
    Napoli, Alessandro
    Zhang, Yonggang
    Karn, Jonathan
    Hu, Wenhui
    Khalili, Kamel
    SCIENTIFIC REPORTS, 2016, 6
  • [23] Elimination of HIV-1 genomes from human T-lymphoid cells by CRISPR/Cas9 gene editing
    Kaminski, Rafal
    Chen, Yilan
    Fischer, Tracy
    Tedaldi, Ellen
    Napoli, Alessandro
    Zhang, Yonggang
    Karn, Jonathan
    Hu, Wenhui
    Khalili, Kamel
    JOURNAL OF NEUROVIROLOGY, 2016, 22 : S35 - S35
  • [24] State-of-art humanized mouse models and the CRISPR/Cas9 TECHNOLOGY AT TaconicArtemis
    Klimke, Alexander
    Kessler, Jeanette
    Guettler, Steffen
    Welcker, Jochen
    Uyttersprot, Nathalie
    Kauselmann, Gunther
    TRANSGENIC RESEARCH, 2014, 23 (05) : 906 - 907
  • [25] Developmental progress of CRISPR/Cas9 and its therapeutic applications for HIV-1 infection
    Deng, Qiudi
    Chen, Zisheng
    Shi, Lei
    Lin, Huafeng
    REVIEWS IN MEDICAL VIROLOGY, 2018, 28 (05)
  • [26] Recent advances in CRISPR/Cas9 technology for targeting latent HIV-1 reservoirs
    Tobin, Stacey C.
    AIDS, 2016, 30 (11) : N17 - N17
  • [27] Targeted Chromatinization and Repression of HIV-1 Provirus Transcription with Repurposed CRISPR/Cas9
    Olson, Alex
    Basukala, Binita
    Lee, Seunghee
    Gagne, Matthew
    Wong, Wilson W.
    Henderson, Andrew J.
    VIRUSES-BASEL, 2020, 12 (10):
  • [28] Humanized Mice for Studies of HIV-1 Persistence and Elimination
    Zhang, Chen
    Zaman, Lubaba A.
    Poluektova, Larisa Y.
    Gorantla, Santhi
    Gendelman, Howard E.
    Dash, Prasanta K.
    PATHOGENS, 2023, 12 (07):
  • [29] Broad-Spectrum and Personalized Guide RNAs for CRISPR/Cas9 HIV-1 Therapeutics
    Dampier, Will
    Sullivan, Neil T.
    Mell, Joshua Chang
    Pirrone, Vanessa
    Ehrlich, Garth D.
    Chung, Cheng-Han
    Allen, Alexander G.
    DeSimone, Mathew
    Zhong, Wen
    Kercher, Katherine
    Passic, Shendra
    Williams, Jean W.
    Szep, Zsofia
    Khalili, Kamel
    Jacobson, Jeffrey M.
    Nonnemacher, Michael R.
    Wigdahl, Brian
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2018, 34 (11) : 950 - 960
  • [30] Latent HIV-1 provirus in vitro suppression using combinatorial CRISPR/Cas9 strategy
    Kalidasan, V.
    Ravichantar, Nithya
    Besari, Alwi Muhd
    Yunus, Muhammad Amir
    Yusoff, Narazah Mohd
    Mohamed, Zeehaida
    Das, Kumitaa Theva
    GENE REPORTS, 2022, 29
12345